vs

Side-by-side financial comparison of Amneal Pharmaceuticals, Inc. (AMRX) and STAR GROUP, L.P. (SGU). Click either name above to swap in a different company.

Amneal Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($722.5M vs $539.3M, roughly 1.3× STAR GROUP, L.P.). Amneal Pharmaceuticals, Inc. runs the higher net margin — 10.8% vs 6.6%, a 4.2% gap on every dollar of revenue. On growth, STAR GROUP, L.P. posted the faster year-over-year revenue change (10.5% vs 3.9%).

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.

Lone Star Funds, legal name of main entity Lone Star Global Acquisitions, Ltd. is a global private equity firm that invests in corporate equity, real estate, credit, and other financial assets. The founder of Lone Star established its first fund in 1995 and Lone Star has to date organized 25 private equity funds with total capital commitments since inception of over $95 billion. Lone Star's investors include corporate and public pension funds, sovereign wealth funds, university endowments, fo...

AMRX vs SGU — Head-to-Head

Bigger by revenue
AMRX
AMRX
1.3× larger
AMRX
$722.5M
$539.3M
SGU
Growing faster (revenue YoY)
SGU
SGU
+6.6% gap
SGU
10.5%
3.9%
AMRX
Higher net margin
AMRX
AMRX
4.2% more per $
AMRX
10.8%
6.6%
SGU

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
AMRX
AMRX
SGU
SGU
Revenue
$722.5M
$539.3M
Net Profit
$78.0M
$35.8M
Gross Margin
44.3%
Operating Margin
19.6%
10.1%
Net Margin
10.8%
6.6%
Revenue YoY
3.9%
10.5%
Net Profit YoY
410.5%
8.8%
EPS (diluted)
$0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRX
AMRX
SGU
SGU
Q1 26
$722.5M
Q4 25
$814.3M
$539.3M
Q3 25
$784.5M
Q2 25
$724.5M
Q1 25
$695.4M
Q4 24
$730.5M
Q3 24
$702.5M
Q2 24
$701.8M
Net Profit
AMRX
AMRX
SGU
SGU
Q1 26
$78.0M
Q4 25
$35.1M
$35.8M
Q3 25
$2.4M
Q2 25
$22.4M
Q1 25
$12.2M
Q4 24
$-31.1M
Q3 24
$-156.0K
Q2 24
$6.0M
Gross Margin
AMRX
AMRX
SGU
SGU
Q1 26
44.3%
Q4 25
36.5%
Q3 25
34.9%
Q2 25
39.5%
Q1 25
36.8%
Q4 24
36.0%
Q3 24
38.4%
Q2 24
35.6%
Operating Margin
AMRX
AMRX
SGU
SGU
Q1 26
19.6%
Q4 25
13.8%
10.1%
Q3 25
9.0%
Q2 25
15.4%
Q1 25
14.4%
Q4 24
10.4%
Q3 24
12.6%
Q2 24
13.6%
Net Margin
AMRX
AMRX
SGU
SGU
Q1 26
10.8%
Q4 25
4.3%
6.6%
Q3 25
0.3%
Q2 25
3.1%
Q1 25
1.8%
Q4 24
-4.3%
Q3 24
-0.0%
Q2 24
0.9%
EPS (diluted)
AMRX
AMRX
SGU
SGU
Q1 26
$0.19
Q4 25
$0.10
Q3 25
$0.01
Q2 25
$0.07
Q1 25
$0.04
Q4 24
$-0.10
Q3 24
$0.00
Q2 24
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRX
AMRX
SGU
SGU
Cash + ST InvestmentsLiquidity on hand
$197.7M
$19.9M
Total DebtLower is stronger
$254.8M
Stockholders' EquityBook value
Total Assets
$3.5B
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRX
AMRX
SGU
SGU
Q1 26
$197.7M
Q4 25
$282.0M
$19.9M
Q3 25
$201.2M
Q2 25
$71.5M
Q1 25
$59.2M
Q4 24
$110.6M
Q3 24
$74.0M
Q2 24
$43.8M
Total Debt
AMRX
AMRX
SGU
SGU
Q1 26
Q4 25
$2.6B
$254.8M
Q3 25
$2.6B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.4B
Q3 24
$2.4B
Q2 24
$2.4B
Stockholders' Equity
AMRX
AMRX
SGU
SGU
Q1 26
Q4 25
$-70.8M
Q3 25
$-109.5M
Q2 25
$-112.1M
Q1 25
$-131.7M
Q4 24
$-109.3M
Q3 24
$-93.4M
Q2 24
$-57.5M
Total Assets
AMRX
AMRX
SGU
SGU
Q1 26
$3.5B
Q4 25
$3.7B
$1.1B
Q3 25
$3.6B
Q2 25
$3.4B
Q1 25
$3.4B
Q4 24
$3.5B
Q3 24
$3.5B
Q2 24
$3.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRX
AMRX
SGU
SGU
Operating Cash FlowLast quarter
$-55.2M
Free Cash FlowOCF − Capex
$-59.7M
FCF MarginFCF / Revenue
-11.1%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
-1.54×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRX
AMRX
SGU
SGU
Q1 26
Q4 25
$130.3M
$-55.2M
Q3 25
$118.5M
Q2 25
$83.8M
Q1 25
$7.4M
Q4 24
$118.1M
Q3 24
$141.8M
Q2 24
$39.7M
Free Cash Flow
AMRX
AMRX
SGU
SGU
Q1 26
Q4 25
$108.5M
$-59.7M
Q3 25
$106.2M
Q2 25
$61.0M
Q1 25
$-5.8M
Q4 24
$102.9M
Q3 24
$124.8M
Q2 24
$29.0M
FCF Margin
AMRX
AMRX
SGU
SGU
Q1 26
Q4 25
13.3%
-11.1%
Q3 25
13.5%
Q2 25
8.4%
Q1 25
-0.8%
Q4 24
14.1%
Q3 24
17.8%
Q2 24
4.1%
Capex Intensity
AMRX
AMRX
SGU
SGU
Q1 26
Q4 25
2.7%
0.8%
Q3 25
1.6%
Q2 25
3.2%
Q1 25
1.9%
Q4 24
2.1%
Q3 24
2.4%
Q2 24
1.5%
Cash Conversion
AMRX
AMRX
SGU
SGU
Q1 26
Q4 25
3.72×
-1.54×
Q3 25
50.00×
Q2 25
3.74×
Q1 25
0.61×
Q4 24
Q3 24
Q2 24
6.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRX
AMRX

Segment breakdown not available.

SGU
SGU

Home Heating Oil And Propane$372.6M69%
Motor Fuel And Other Petroleum Products$75.4M14%
Equipment Installations$39.6M7%
Equipment Maintenance Service Contracts$30.3M6%
Billable Call Services$21.4M4%

Related Comparisons